Replies to post #85214 on Biotech Values

[jbog]

gensi,

I find it somewhat uncomfortable that these huge companies are not fullfilling the FDA data needs upfront.

Amgen and NVS are not rookies so it's either they are getting sloppy (I doubt it) or the FDA is making new rules as they go thru the process.

This is the situation that I fear for companies like mnta.